<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7">
 <label>7.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Meyerowitz</surname>
    <given-names>E</given-names>
   </name>, 
   <name name-style="western">
    <surname>Vannier</surname>
    <given-names>AGL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Friesen</surname>
    <given-names>MGN</given-names>
   </name>, 
   <name name-style="western">
    <surname>Schoenfeld</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gelfand</surname>
    <given-names>JA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Callahan</surname>
    <given-names>MV</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kim</surname>
    <given-names>AY</given-names>
   </name>, 
   <name name-style="western">
    <surname>Reeves</surname>
    <given-names>PM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Poznansky</surname>
    <given-names>MC</given-names>
   </name>
  </person-group>
  <year>2020</year>
  <article-title>Rethinking the role of hydroxychloroquine in the treatment of COVID-19</article-title>. 
  <source>FASEB J</source>
  <volume>34</volume>:
  <fpage>6027</fpage>â€“
  <lpage>6037</lpage>. doi:
  <pub-id pub-id-type="doi">10.1096/fj.202000919</pub-id>.
  <pub-id pub-id-type="pmid">32350928</pub-id>
 </mixed-citation>
</ref>
